Real-time enrollment status for this waldenström's macroglobulinemia clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05952037 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Waldenström's Macroglobulinemia |
| Phase | Clinical Trial |
| Target Enrollment | 105 participants |
| Active Locations | 17 sites in the US |
| Sponsor | BeiGene |
| Last Updated on CT.gov | January 2, 2026 (Jan 2, 2026) |
As of March 2, 2026: Clinical trial NCT05952037 is currently active_not_recruiting participants. This clinical trial study for waldenström's macroglobulinemia is not currently accepting new participants at 17 locations across the United States. The study is sponsored by BeiGene. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05952037 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05952037 was last updated Jan 2, 2026 (January 2, 2026). HelloStudys verifies this status automatically.